Age-based differences in the diagnosis and management of esophageal eosinophilia

J Allergy Clin Immunol Pract. 2015 Jan-Feb;3(1):81-87.e1. doi: 10.1016/j.jaip.2014.06.019. Epub 2014 Oct 29.

Abstract

Background: Eosinophilic esophagitis (EoE) is hallmarked by esophageal eosinophilia, >15 eosinophils(eos)/high-powered field (hpf), unresponsive to acid inhibition, and varied symptomatology. EoE consensus guidelines do not discriminate based on age for initiating treatment.

Objective: To evaluate if age-related differences exist in managing esophageal eosinophilia and EoE within a university population.

Methods: In a retrospective cohort study from a referral center, the medical records of 426 pediatric and adult patients with at least 1 presenting symptom of esophagitis, reflux, or upper gastrointestinal dysfunction, who underwent esophageal biopsy between 2009 and 2011 were analyzed for age-based differences in care in diagnosing and managing esophageal eosinophilia.

Results: For these patients, 79.6% (336/426) had ≥15 eos/hpf in biopsy specimens, which was not associated with age. Significantly fewer adults than children with ≥15 eos/hpf were diagnosed with EoE (P < .001), referred for allergy evaluation (P < .001), started on swallowed steroid therapy (P < .001), or underwent repeated biopsy (P < .001). Increasing age, atopy, and increasing biopsy peak eos count moderated these effects, but the adjusted predicted probabilities for these outcomes were significantly lower among adults. Restriction for an 8-week prebiopsy proton-pump inhibitor trial did not alter the age-based relationships for an allergy referral or repeated biopsy.

Conclusions: Numerous age-based differences in the management of symptomatic patients with esophageal eosinophilia existed in this cohort. Adults were significantly less likely than children to receive a clinical diagnosis of EoE, allergy referral, or steroid treatment, or to have a repeated biopsy. Even when stratified for an 8-week prebiopsy proton-pump inhibitor trial, advancing age was associated with lower odds of referral or repeated biopsy. Further study is necessary to better understand why discrepancies exist and their potential ramifications.

Keywords: Adults; Age; Allergy; Biopsy; Care pathways; Children; Dietary therapy; Dilation; Dysphagia; Eosinophil; Eosinophilic esophagitis; Esophageal biopsy; Esophagogastroduodenoscopy; GERD; Health disparities; Swallowed steroid therapy; TIGER.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Age Factors
  • Biopsy
  • Cohort Studies
  • Eosinophilic Esophagitis / diagnosis*
  • Eosinophilic Esophagitis / pathology
  • Eosinophilic Esophagitis / therapy*
  • Female
  • Humans
  • Male
  • Proton Pump Inhibitors / therapeutic use
  • Referral and Consultation / statistics & numerical data
  • Retrospective Studies
  • Young Adult

Substances

  • Adrenal Cortex Hormones
  • Proton Pump Inhibitors